FrancophonIA/ELRC3.0 huggingface dataset:
English: Tobi Podhaler was studied in two main trials in patients who had cystic fibrosis with P. aeruginosa lung infection.
Croatian: Tobi Podhaler ispitivan je u dva glavna ispitivanja u bolesnika s cističnom fibrozom i infekcijom pluća uzrokovanom bakterijom P. aeruginosa.
English: Tobi Podhaler was more effective than placebo in treating P. aeruginosa infection in patients with cystic fibrosis.
Croatian: Lijek Tobi Podhaler pokazao se učinkovitijim od placeba u liječenju infekcija uzrokovanih bakterijom P. aeruginosa u bolesnika s cističnom fibrozom.
English: For the full list of all side effects reported with Tobi Podhaler, see the package leaflet.
Croatian: Potpuni popis svih nuspojava zabilježenih pri primjeni lijeka Tobi Podhaler potražite u uputi o lijeku.
English: What is Tobi Podhaler used for?
Croatian: Za što se Tobi Podhaler koristi?
English: What benefit has Tobi Podhaler shown during the studies?
Croatian: Koje su koristi lijeka Tobi Podhaler utvrđene u ispitivanjima?
English: How is Tobi Podhaler used?
Croatian: Kako se koristi Tobi Podhaler?
English: How has Tobi Podhaler been studied?
Croatian: Kako je Tobi Podhaler ispitivan?
English: This overview was last updated in 01-2019.
Croatian: Ovaj sažetak je posljednji put ažuriran u siječnju 2019.
English: This means that it contains the same active substances and works in the same way as a ‘reference medicine' already authorised in the EU called Truvada.
Croatian: To znači da sadržava iste djelatne tvari i djeluje na isti način kao i „referentni lijek” koji je već odobren u EU-u pod nazivom Truvada.
English: It should be used in combination with safer sex practices, such as use of condoms.
Croatian: Lijek se treba primjenjivati u kombinaciji sa zaštićenim spolnim odnosom, kao što je upotreba prezervativa.
English: The recommended dose for treating or preventing HIV-1 infection is one tablet once a day, preferably taken with food.
Croatian: Preporučena doza za liječenje ili sprečavanje infekcije virusom HIV-1 jest jedna tableta jedanput na dan, a poželjno je da se uzima s hranom.
English: Emtricitabine/Tenofovir disoproxil Mylan received a marketing authorisation valid throughout the EU on 16 December 2016.
Croatian: Lijek Emtricitabine / Tenofovir disoproxil Mylan dobio je odobrenje za stavljanje u promet koje je na snazi u EU-u od 16. prosinca 2016.
English: Further information on Emtricitabine/Tenofovir disoproxil Mylan can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/emtricitabinetenofovir-disoproxil-mylan.
Croatian: Više informacija o lijeku Emtricitabine / Tenofovir disoproxil Mylan nalazi se na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/emtricitabinetenofovir-disoproxil-mylan.
English: Emtricitabine/Tenofovir disoproxil Mylan does not cure HIV infection or AIDS, but it holds off damage to the immune system and the development of infections and diseases associated with AIDS.
Croatian: Emtricitabine / Tenofovir disoproxil Mylan ne liječi infekciju HIV-om ni AIDS, no može odgoditi oštećenje imunosnog sustava i razvoj infekcija i bolesti povezanih s AIDS-om.
English: If patients need to stop taking emtricitabine or tenofovir, or need to take different doses, they will need to take medicines containing emtricitabine or tenofovir disoproxil separately.
Croatian: Ako bolesnici moraju prekinuti liječenje emtricitabinom ili tenofovirom, odnosno uzimati drugačije doze, tada moraju odvojeno uzimati lijekove koji sadrže emtricitabin ili tenofovirdizoproksil.
English: Side effects reported with Emtricitabine/Tenofovir disoproxil Mylan are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Emtricitabine / Tenofovir disoproxil Mylan pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: Studies on the benefits and risks of the active substances in the authorised uses have already been carried out with the reference medicine, Truvada, and do not need to be repeated for Emtricitabine/Tenofovir disoproxil Mylan.
Croatian: Ispitivanja koristi i rizika od djelatnih tvari u odobrenoj primjeni već su provedena s referentnim lijekom Truvada i stoga ih nije potrebno ponavljati za Emtricitabine/Tenofovir disoproxil Mylan.
English: The European Medicines Agency concluded that, in accordance with EU requirements, Emtricitabine/Tenofovir disoproxil Mylan has been shown to have comparable quality and to be bioequivalent to Truvada.
Croatian: Europska agencija za lijekove zaključila je kako je, u skladu sa zahtjevima EU-a, utvrđeno da lijek Emtricitabine / Tenofovir disoproxil Mylan posjeduje usporedivu kakvoću te da je bioekvivalentan s lijekom Truvada.
English: In addition, it may be used in adolescents with HIV who are resistant to first-line treatments or who cannot take them because of side effects.
Croatian: Osim toga, može se primjenjivati u adolescenata koji su zaraženi HIV-om, a kod kojih je zabilježena rezistencija na prvu liniju liječenja ili ne mogu primati liječenje zbog nuspojava.
English: Because Emtricitabine/Tenofovir disoproxil Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je lijek Emtricitabine / Tenofovir disoproxil Mylan generički lijek te da je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: The company that markets Emtricitabine/Tenofovir disoproxil Mylan will provide an information pack to doctors which covers the potential harmful effects of Emtricitabine/Tenofovir disoproxil Mylan on kidney function and information about use for pre-exposure prophylaxis.
Croatian: Tvrtka koja stavlja u promet lijek Emtricitabine / Tenofovir disoproxil Mylan osigurat će informativni paket za liječnike koji obuhvaća potencijalne štetne učinke lijeka Emtricitabine/Tenofovir disoproxil Mylan na funkciju bubrega i informacije za primjenu u predekspozicijskoj profilaksi.
English: For pre-exposure prophylaxis of HIV-1 infection, it is expected that Emtricitabine/Tenofovir disoproxil Mylan in the blood will stop the virus from multiplying and spreading from the site of infection in case the individual is exposed to the virus.
Croatian: Kada je riječ o predekspozicijskoj profilaksi infekcije virusom HIV-1, očekuje se da će Emtricitabine / Tenofovir disoproxil Mylan u krvi zaustaviti razmnožavanje virusa i širenje s mjesta infekcije ako je osoba izložena virusu.
English: Emtricitabine/Tenofovir disoproxil Mylan is available as tablets (200 mg emtricitabine and 245 mg tenofovir disoproxil).
Croatian: Lijek Emtricitabine / Tenofovir disoproxil Mylan dostupan je u obliku tableta (200 mg emtricitabina i 245 mg tenofovirdizoproksila).
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Emtricitabine/Tenofovir disoproxil Mylan have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Emtricitabine / Tenofovir disoproxil Mylan također se nalaze u sažetku opisa svojstava i uputi o lijeku.
English: Emtricitabine/Tenofovir disoproxil Mylan can only be obtained with a prescription and treatment should be started by a doctor who has experience in the management of HIV infection.
Croatian: Emtricitabine / Tenofovir disoproxil Mylan izdaje se samo na liječnički recept, a liječenje mora započeti liječnik s iskustvom u liječenju infekcije HIV-om.
English: Emtricitabine/Tenofovir disoproxil Mylan is an HIV medicine that is used in combination with at least one other HIV medicine to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Croatian: Lijek Emtricitabine / Tenofovir disoproxil Mylan lijek je protiv HIV-a koji se primjenjuje u kombinaciji s najmanje još jednim lijekom protiv HIV-a za liječenje odraslih osoba zaraženih virusom humane imunodeficijencije tipa 1 (HIV-1), virusom koji uzrokuje sindrom stečene imunodeficijencije (AIDS).
English: For more information about using Emtricitabine/Tenofovir disoproxil Mylan, see the package leaflet or contact your doctor or pharmacist.
Croatian: Više informacija o primjeni lijeka Emtricitabine / Tenofovir disoproxil Mylan pročitajte u uputi o lijeku, odnosno obratite se liječniku ili ljekarniku.
English: Emtricitabine/Tenofovir disoproxil Mylan (emtricitabine / tenofovir disoproxil)
Croatian: Emtricitabine / Tenofovir disoproxil Mylan (emtricitabin/tenofovirdizoproksil)
English: Therefore, the Agency's view was that, as for Truvada, the benefit of Emtricitabine/Tenofovir disoproxil Mylan outweighs the identified risk and it can be authorised for use in the EU.
Croatian: Stoga je stav Agencije da korist od lijeka Emtricitabine / Tenofovir disoproxil Mylan, kao i od lijeka Truvada, nadmašuje identificirani rizik te da lijek može biti odobren za primjenu u EU-u.
English: Emtricitabine/Tenofovir disoproxil Mylan is also used to help prevent sexually transmitted HIV-1 infection in adults and adolescents who are at high risk of being infected (pre-exposure prophylaxis or PrEP).
Croatian: Emtricitabine / Tenofovir disoproxil Mylan primjenjuje se i za sprečavanje spolno prenosive infekcije virusom HIV-1 u odraslih osoba i adolescenata kod kojih postoji veliki rizik od infekcije („predekspozicijska profilaksa”).
English: What measures are being taken to ensure the safe and effective use of Emtricitabine/Tenofovir disoproxil Mylan?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Emtricitabine / Tenofovir disoproxil Mylan?
English: An overview of Emtricitabine/Tenofovir disoproxil Mylan and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Emtricitabine / Tenofovir disoproxil Mylan i zašto je odobren u EU-u
English: Other information about Emtricitabine/Tenofovir disoproxil Mylan
Croatian: Ostale informacije o lijeku Emtricitabine / Tenofovir disoproxil Mylan
English: Emtricitabine/Tenofovir disoproxil Mylan contains two active substances, emtricitabine and tenofovir disoproxil.
Croatian: Emtricitabine / Tenofovir disoproxil Mylan sadržava dvije djelatne tvari, emtricitabin i tenofovirdizoproksil.
English: As for every medicine, the company provided studies on the quality of Emtricitabine/Tenofovir disoproxil Mylan.
Croatian: Kao i za svaki lijek, tvrtka je dostavila podatke o ispitivanjima kakvoće lijeka Emtricitabine / Tenofovir disoproxil Mylan.
English: As for all medicines, data on the use of Emtricitabine/Tenofovir disoproxil Mylan are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Emtricitabine / Tenofovir disoproxil Mylan kontinuirano se prate.
English: What is Emtricitabine/Tenofovir disoproxil Mylan and what is it used for?
Croatian: Što je Emtricitabine / Tenofovir disoproxil Mylan i za što se primjenjuje?
English: What are the benefits and risks of Emtricitabine/Tenofovir disoproxil Mylan?
Croatian: Koje su koristi i rizici od lijeka Emtricitabine / Tenofovir disoproxil Mylan?
English: For the treatment of HIV-infection, Emtricitabine/Tenofovir disoproxil Mylan, taken in combination with at least one other HIV medicine, reduces the amount of HIV in the blood and keeps it at a low level.
Croatian: Kad se uzima u kombinaciji s najmanje još jednim lijekom protiv HIV-a, Emtricitabine / Tenofovir disoproxil Mylan smanjuje koncentraciju HIV-a u krvi i održava je na niskoj razini.
English: Emtricitabine/Tenofovir disoproxil Mylan contains two active substances: emtricitabine, which is a nucleoside reverse transcriptase inhibitor; and tenofovir disoproxil, which is a ‘prodrug' of tenofovir.
Croatian: Emtricitabine / Tenofovir disoproxil Mylan sadržava dvije djelatne tvari: emtricitabin, nukleozidni inhibitor reverzne transkriptaze, i tenofovirdizoproksil, „prolijek” tenofovira.
English: Why is Emtricitabine/Tenofovir disoproxil Mylan authorised in the EU?
Croatian: Zašto je lijek Emtricitabine/Tenofovir disoproxil Mylan odobren u EU-u?
English: How is Emtricitabine/Tenofovir disoproxil Mylan used?
Croatian: Kako se primjenjuje Emtricitabine / Tenofovir disoproxil Mylan?
English: How does Emtricitabine/Tenofovir disoproxil Mylan work?
Croatian: Kako djeluje Emtricitabine / Tenofovir disoproxil Mylan?
English: What Iscover is and what it is used for
Croatian: Što je Iscover i za što se koristi
English: Some other medicines may influence the use of Iscover or vice versa.
Croatian: Neki lijekovi mogu utjecati na djelovanje lijeka Iscover i obratno.
English: While you are taking Iscover:
Croatian: Dok uzimate Iscover:
English: The other ingredients are (see section 2 ‘Iscover contains lactose' and ‘Iscover contains hydrogenated castor oil'):
Croatian: Drugi sastojci su (vidjeti dio 2. „Iscover sadrži laktozu“ i „Iscover sadrži hidrogenirano ricinusovo ulje“):
English: 67019 Scoppito (AQ) - Italy
Croatian: 67019 Scoppito (AQ) - Italija
English: You should take Iscover for as long as your doctor continues to prescribe it.
Croatian: Iscover trebate uzimati sve dok Vam ga liječnik propisuje.
English: Other medicines and Iscover
Croatian: Drugi lijekovi i Iscover
English: Strada Statale 17, Km 22 67019 Scoppito (AQ) - Italy
Croatian: Strada Statale 17, Km 22 67019 Scoppito (AQ) - Italija
English: For the 7, 14, 28 and 84 tablets pack sizes, you can check the day on which you last took a tablet of Iscover by referring to the calendar printed on the blister.
Croatian: Za pakiranja od 7, 14, 28 i 84 tablete možete provjeriti dan kada ste zadnji put uzeli tabletu lijeka Iscover pomoću kalendara otisnutog na blisteru.
English: You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Iscover and acetylsalicylic acid for this condition.
Croatian: Trebalo Vam je biti rečeno da su za ovo stanje 'oralni antikoagulansi' učinkovitiji od acetilsalicilatne kiseline ili kombinirane primjene lijeka Iscover i acetilsalicilatne kiseline.
English: What Iscover looks like and contents of the pack
Croatian: Kako Iscover izgleda i sadržaj pakiranja
English: Iscover contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products.
Croatian: Iscover sadrži klopidogrel i pripada skupini lijekova koji se nazivaju antitrombocitni lijekovi.
English: Your doctor should have prescribed Iscover plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding.
Croatian: Liječnik Vam treba propisati Iscover i acetilsalicilatnu kiselinu ako ne možete uzimati oralne antikoagulanse te nemate rizik od velikog krvarenja.
English: As a precautionary measure, breast-feeding should not be continued during treatment with Iscover.
Croatian: Kao mjera opreza, treba prestati s dojenjem za vrijeme liječenja lijekom Iscover.
English: If you forget to take Iscover
Croatian: Ako ste zaboravili uzeti Iscover
English: This is linked to the way your medicine works as it prevents the ability of blood clots to form.
Croatian: To je povezano s načinom na koji djeluje Vaš lijek, jer sprječava mogućnost stvaranja krvnih ugrušaka.
English: If any of the situations mentioned below apply to you, you should tell your doctor before taking Iscover:
Croatian: Ako se na Vas odnosi bilo koje od dolje navedenih stanja morate obavijestiti liječnika, prije nego što uzmete Iscover:
English: If you become pregnant while taking Iscover, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant.
Croatian: Ako zatrudnite za vrijeme uzimanja lijeka Iscover, odmah se posavjetujte s liječnikom, jer nije preporučeno uzimati klopidogrel za vrijeme trudnoće.
English: What you need to know before you take Iscover Do not take Iscover
Croatian: Što morate znati prije nego počnete uzimati Iscover Nemojte uzimati Iscover
English: 5 How to store Iscover Contents of the pack and other information
Croatian: Kako čuvati Iscover Sadržaj pakiranja i druge informacije
English: What Iscover is and what it is used for What you need to know before you take Iscover How to take Iscover
Croatian: Što je Iscover i za što se koristi Što morate znati prije nego počnete uzimati Iscover Kako uzimati Iscover
English: If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Iscover in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever.
Croatian: Ako ste imali jaku bol u prsištu (nestabilna angina ili srčani udar), liječnik Vam može propisati Iscover u kombinaciji s acetilsalicilatnom kiselinom, tvari prisutnom u mnogim lijekovima za ublažavanje boli i snižavanje temperature.
English: The recommended dose, including for patients with a condition called ‘atrial fibrillation' (an irregular heartbeat), is one 75 mg tablet of Iscover per day to be taken orally with or without food, and at the same time each day.
Croatian: Preporučena doza, uključujući za bolesnike sa stanjem zvanim "fibrilacija atrija" (nepravilni otkucaji srca), je jedna tableta lijeka Iscover od 75 mg dnevno koja se uzima kroz usta, s obrokom ili bez obroka, i u isto vrijeme svaki dan.
English: How to take Iscover
Croatian: Kako uzimati Iscover
English: If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Iscover.
Croatian: Ako ste trudni ili sumnjate na trudnoću, obavijestite svog liječnika ili ljekarnika prije nego što uzmete Iscover.
English: If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Iscover (1 tablet of 300 mg or 4 tablets of 75 mg) once at the start of treatment.
Croatian: Ako ste imali jake bolove u prsištu (nestabilna angina ili srčani udar), liječnik Vam u početku liječenja može jednokratno dati 300 mg lijeka Iscover (1 tableta od 300 mg ili 4 tablete od po 75 mg).
English: If you forget to take a dose of Iscover, but remember within 12 hours of your usual time, take your tablet straightaway and then take your next tablet at the usual time.
Croatian: Ako zaboravite uzeti jednu dozu lijeka Iscover, ali se toga sjetite u roku od 12 sati, odmah uzmite tabletu, a sljedeću tabletu uzmite u uobičajeno vrijeme.
English: If you stop taking Iscover Do not stop the treatment unless your doctor tells you so.
Croatian: Ne prekidajte liječenje osim ako Vam to ne savjetuje liječnik.
English: Then, the recommended dose is one 75 mg tablet of Iscover per day as described above.
Croatian: Nakon toga, preporučena doza lijeka Iscover je jedna tableta od 75 mg dnevno, kao što je opisano iznad.
English: If you experience prolonged bleeding when taking Iscover
Croatian: Ako pri uzimanju lijeka Iscover imate produljeno krvarenje
English: Do not use this medicine after the expiry date which is stated on the carton and on the blister, after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i blisteru iza oznake "Rok valjanosti".
English: Iscover may be taken with or without food.
Croatian: Iscover s hranom i pićem Iscover se može uzimati s obrokom ili bez obroka.
English: Iscover contains hydrogenated castor oil
Croatian: Iscover sadrži hidrogenirano ricinusovo ulje
English: Contact your doctor or the nearest hospital emergency department because of the increased risk of bleeding.
Croatian: Ako uzmete više lijeka Iscover nego što ste trebali Odmah morate kontaktirati liječnika ili najbliži odjel hitne medicinske pomoći zbog povećanog rizika od krvarenja.
English: You have been prescribed Iscover to help prevent blood clots and reduce the risk of these severe events because: - You have a condition of hardening of arteries (also known as atherosclerosis), and - You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease, or - You have experienced a severe type of chest pain known as ‘unstable angina' or ‘myocardial infarction' (heart attack).
Croatian: Iscover Vam je propisan za sprječavanje stvaranja krvnih ugrušaka i smanjivanje opasnosti od ovih ozbiljnih događaja jer: - imate otvrdnuće arterija (koje se još zove ateroskleroza) te - ste već imali srčani udar, moždani udar ili imate stanje koje se zove bolest perifernih arterija, ili - ste imali teški oblik boli u prsištu, poznat pod nazivom “nestabilna angina” ili “infarkt miokarda” (srčani udar).
English: - If you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain.
Croatian: • ako imate poremećaj koji izaziva krvarenje, kao što je, primjerice, želučani čir ili krvarenje u mozgu
English: Iscover is taken by adults to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).
Croatian: Iscover uzimaju odrasli za sprječavanje stvaranja krvnih ugrušaka (tromba) u otvrdnutim krvnim žilama (arterijama), a taj poremećaj zove se aterotromboza i može dovesti do aterotrombotičkih događaja (kao što su moždani udar, srčani udar ili smrt).
English: If Iscover is supplied in all aluminium blisters, it does not require any special storage conditions.
Croatian: Ako je Iscover opremljen u aluminijske blistere, lijek ne zahtijeva posebne uvjete čuvanja.
English: The dose of 0.2 mg/kg achieved the mean percent inhibition of 49.3% (5 µM ADP-induced platelet aggregation) which was comparable to that of adults taking Iscover 75 mg/day.
Croatian: S dozom od 0,2 mg/kg postignut je prosječni postotak inhibicije od 49,3% (5 µM ADP-om inducirane agregacije trombocita), što je usporedivo s postotkom u odraslih koji uzimaju Iscover u dozi od 75 mg/dnevno.
English: The most common side effect reported with Iscover is bleeding.
Croatian: Najčešća nuspojava lijeka Iscover jest krvarenje.
English: How to store Iscover
Croatian: Kako čuvati Iscover
English: If Iscover is supplied in PVC/PVDC/aluminium blisters, store below 30°C.
Croatian: Ako je Iscover opremljen u PVC/PVDC/aluminij blistere, čuvati na temperaturi ispod 30°C.
English: Iscover is unlikely to affect your ability to drive or to use machines.
Croatian: Upravljanje vozilima i strojevima Iscover ne bi trebao utjecati na Vašu sposobnost upravljanja vozilima ili strojevima.
English: Iscover contains lactose.
Croatian: Iscover sadrži laktozu.
English: Iscover 75 mg film-coated tablets Clopidogrel should be given as a single daily dose of 75 mg.
Croatian: Iscover 75 mg filmom obložene tablete Klopidogrel se daje u jednokratnoj dnevnoj dozi od 75 mg.
English: Marketing Authorisation Holder: sanofi-aventis groupe 54, rue La Boétie F-75008 Paris
Croatian: Nositelj odobrenja: sanofi-aventis groupe 54, rue La Boétie F-75008 Pariz Francuska
English: Iscover is supplied in cardboard cartons containing 4x1, 10x1, 30x1 and 100x1 tablets in all aluminium perforated unit-dose blisters.
Croatian: Iscover je dostupan u kartonskim kutijama koje sadrže: 4x1, 10x1, 30x1 ili 100x1 tableta u perforiranim aluminijskim blisterima s jediničnim dozama.
English: Iscover contains lactose
Croatian: Iscover sadrži laktozu
English: - efavirenz, or other anti-retroviral medicines (used to treat HIV infections), - carbamazepine, a medicine to treat some forms of epilepsy, - moclobemide, medicine to treat depression, - repaglinide, medicine to treat diabetes, - paclitaxel, medicine to treat cancer, - opioids: while you are treated with clopidogrel, you should inform your doctor before being prescribed any opioid (used to treat severe pain).
Croatian: - karbamazepin, lijek koji se primjenjuje za liječenje nekih oblika epilepsije, - moklobemid, lijek za liječenje depresije, - repaglinid, lijek za liječenje dijabetesa, - paklitaksel, lijek za liječenje raka, - opioide: dok se liječite klopidogrelom, potrebno je o tome obavijestiti svog liječnika prije nego što
English: Iscover 300 mg film-coated tablets This 300 mg tablet of clopidogrel is intended for use as a loading dose.
Croatian: Ova tableta od 300 mg klopidogrela namijenjena je za uporabu kao udarna doza.